Original Source(s)
Related Content
FDA Approves First Gene Therapy for Sanfilippo Syndrome Type A
Fayuvi is authorized for pediatric patients with preserved neurodevelopmental function following a study comparing treated children with a natural history cohort
September 30, 2026
-
3 min